Cadila Pharma founder I A Modi dies

Details awaited...

Image
Sohini Das New Delhi
Last Updated : Jan 20 2013 | 6:29 AM IST

Veteran industrialist and the founder chairman of Ahmedabad-based privately held pharmaceutical firm Cadila Pharmaceuticals Ltd Indravadan A Modi passed away in Ahmedabad on Monday. The 87 year old who was suffering from respiratory disorder and was admitted at a city hospital breathed his last at around 5:00 pm today. 

Born in a small village of Hansot of Bharuch district in South Gujarat on February 18, 1926, Modi pursued higher studies at Bombay University where his chosen area of study was pharmaceuticals and fine chemicals. The idea to manufacture medicines germinated in his mind at that time and Modi quit his job as a chemist in a chemical manufacturing unit and launched Cadila Laboratories in 1951 as a partnership with a school friend Ramanbhai B Patel. The two friends, however, parted ways in 1995 and Cadila Pharmaceuticals came into being.

Typical of a start-up Cadila had no depth of management.Modi was the producer, promoter, distributor and deliveryman-all rolled into one. He was also the manager, administrator and accountant of his business. His wife and grand mother helped him in chores up to the packing stage. He drew a paltry Rs 250  a month for sustenance and whatever additional revenues that were generated were ploughed back into business.

Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, a company release said. Over the last six decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over 90 other countries around the world. An integrated healthcare solutions provider with pharmaceutical product basket, the company caters to over 45 therapeutic areas that include cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.

Modi is revered in the Indian Pharmaceutical Industry as the Champion of Indian Patents Act, 1970. He played a major role in giving shape to the 1986 Drug Policy of Government of India.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 26 2012 | 6:51 PM IST

Next Story